Kungsbacka, Sweden

Ake G Pilbrant

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 393(Granted Patents)


Company Filing History:


Years Active: 1988-1989

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ake G Pilbrant: Innovator in Pharmaceutical Advancements

Introduction

Ake G Pilbrant, an inventive mind based in Kungsbacka, Sweden, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, he is recognized for his work on formulations that enhance the efficacy of acid-labile substances for oral administration. His innovations have the potential to improve treatments for gastrointestinal diseases.

Latest Patents

Ake G Pilbrant's latest patents focus on advanced pharmaceutical preparations. The first patent deals with "Pharmaceutical formulations of acid-labile substances for oral use." This invention describes a preparation containing an acid-labile compound alongside an alkaline-reacting compound or an alkaline salt. It may also include one or more subcoating layers made of inert compounds that dissolve or disintegrate quickly in water, thus enhancing the drug's stability and bioavailability. The use of enteric coating further supports its application in treating gastrointestinal diseases.

The second patent is for a preparation specifically containing omeprazole, combined with similar alkaline components and subcoating layers as outlined in his first patent. This innovation aims to ensure the effective delivery of omeprazole while minimizing degradation through the gastrointestinal tract.

Career Highlights

Ake G Pilbrant is affiliated with Aktiebolaget Hassle, where he continues to advance pharmaceutical innovations. His dedication to enhancing drug formulations has made a noteworthy impact on treatment strategies within the medical community, particularly in the realm of gastrointestinal health.

Collaborations

Throughout his career, Ake has collaborated with esteemed colleagues such as Kurt I Lovgren and Mitsuru Yasumura. These partnerships have allowed for a cross-pollination of ideas and insights, fostering a rich environment for innovation and development in pharmaceutical sciences.

Conclusion

Ake G Pilbrant stands as a prominent figure in the pharmaceutical industry with his inventive approach to drug formulation. His contributions are not only recognized through his patents but also through the collaborative efforts with other professionals in the field, making meaningful strides in the treatment of gastrointestinal diseases. His work exemplifies the potential of dedicated inventors to transform healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…